Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Control ChangeItem 5.01 · 8-KLOW RiskNeutral

Medline Inc.

Filed: Jun 11, 2026CIK: 0002046386
View on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Medline Inc. held its 2026 Annual Meeting of Stockholders on June 11, 2026, where shareholders voted on director elections, executive compensation approval, and auditor ratification. This routine governance event reflects standard corporate oversight and leadership continuity.

Key Takeaways

12 director nominees were elected as outlined in the April 23, 2026 proxy statement

Shareholders approved executive compensation on an advisory basis

1 more takeaway

Filing Overview

Form Type8-K
Filing DateJun 11, 2026
Item5.01
CategoryControl Change
CIK0002046386
Accession #mdln-20260611
Risk LevelLOW
SentimentNeutral
Signalinformational
Topics
board change

What This Means

Control of the company has changed. This could be through acquisition, proxy contest, or board restructuring.
View Full Filing on SEC.govBrowse More Filings